YOLFTbeta
Emvision Medical Devices Ltd

Emvision Medical Devices Ltd

EMV · AU · Healthcare / Medical Devices

1.43AUD-0.05 (-3.39%)

Price History

Full chart

Market Stats

Previous Close1.48
Open1.48
Day Range1.41 – 1.48
52-Week Range1.47 – 1.96
Volume51.95K
Market Cap145.01M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.09
Dividend Yield0.00%
Beta1.06
50-Day Avg1.70
200-Day Avg1.70

About

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Scott Philip Kirkland
  • Employees0
  • Headquarters65 Epping Road, Macquarie Park, NSW, Australia, 2113, Australia
  • Websitehttps://www.emvision.com.au

Leadership

  • Mr. Scott Philip KirklandCo-founder, CEO, MD & Executive Director
  • Mr. Karl David Pechmann AGIA, B.B.A., C.A.Chief Financial Officer
  • Ms. Forough KhandanChief Technology Officer
  • Dr. Stuart Crozier B.E., M.Sc., Ph.D.Chief Scientific Officer & Member of Clinical Advisory Board
  • Dr. Konstanty BialkowskiHead of Tech Development
  • Dr. Christian WightHead of Regulatory, Quality & Clinical Operations
  • Ms. Emma WaldonCompany Secretary · b. 1976

Financials

Income Statement

Currency: AUD2018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue492.67K1.14M980.72K1.70M4.36M6.97M11.22M5.05M-
Growth (%)-+130.44%-13.62%+73.23%+156.66%+59.92%+60.89%-54.97%-
Cost of Revenue0--113.96K243.34K342.01K410.58K408.49K416.90K
Gross Profit492.67K1.41M1.55M1.58M4.12M6.63M11.22M5.05M-416.90K
Gross Margin100.00%124.59%158.20%93.29%94.42%95.10%100.00%100.00%-
Operating Expense1.83M4.37M5.03M11.77M14.58M17.56M12.83M13.18M16.51M
Operating Income-1.34M-2.96M-3.48M-10.18M-10.47M-10.93M-1.61M-8.13M-16.93M
Operating Margin-271.43%-260.60%-354.35%-599.48%-240.05%-156.72%-14.39%-160.91%-
EBITDA-1.34M-2.96M-3.48M-9.56M-7.84M-5.99M-8.35M-8.71M-16.51M
EBITDA Margin-271.43%-260.60%-354.35%-562.46%-179.76%-85.97%-74.44%-172.44%-
Net Income-845.04K-2.96M-5.08M-8.40M-6.11M-3.87M-2.73M-9.81M-8.32M
Net Income Margin-171.52%-260.67%-517.77%-494.36%-140.11%-55.51%-24.33%-194.10%-
R&D955.88K1.96M2.94M2.71M2.33M2.01M4.70M4.04M4.96M
R&D as % of Total Revenue194.02%172.68%299.32%159.39%53.33%28.85%41.87%79.88%-
Interest Expense4677615979.84K18.12K35.28K115.72K88.57K203.44K
Interest Expense % of Total Revenue0.09%0.07%0.06%0.58%0.42%0.51%1.03%1.75%-

Balance Sheet

Currency: AUD2018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets1.61M5.06M6.01M10.77M8.51M11.52M23.97M15.57M23.04M
Total Liabilities335.61K460.06K489.73K720.01K1.43M6.40M5.46M6.29M7.27M
Total Equity1.28M4.60M5.52M10.05M7.08M5.12M18.52M9.28M15.77M
Cash1.02M4.38M5.41M9.69M6.80M9.97M18.60M10.46M17.10M
Total Debt--213.17K213.17K737.86K3.04M2.90M3.53M3.41M
Net Debt-1.02M-4.38M-5.41M-9.48M-6.06M-6.93M-15.70M-6.92M-13.70M

Cash Flow

Currency: AUD2018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-679.59K-2.22M-3.26M-4.49M-3.78M834.15K-5.99M-7.84M-6.25M
Investing Cash Flow-127.25K-2.22M-127.25K-127.25K-191.12K-187.29K-302.41K-50.37K-124.22K
Financing Cash Flow1.70M5.58M4.28M8.90M1.08M2.52M15.00M-258.34K13.02M
Capital Expenditure127.25K127.25K127.25K127.25K191.12K187.29K302.41K50.37K124.21K
Free Cash Flow-679.59K-2.22M-3.26M-4.62M-3.97M646.86K-6.29M-7.89M-6.37M
Dividends Paid-----2.74M---
FCF to OCF100.00%100.00%100.00%102.83%105.05%77.55%105.05%100.64%101.99%
Dividend Paid to FCF-----423.36%---

Earnings

Report DateDec 11, 2018Feb 26, 2019Aug 30, 2019Feb 27, 2020Aug 26, 2020Feb 24, 2021Aug 31, 2021Feb 23, 2022Aug 30, 2022Mar 3, 2023Feb 27, 2025Aug 27, 2025
EPS Estimate0.000.000.000.000.000.00-0.00--0.000.00
EPS Actual-0.01-0.03-0.02-0.03-0.03-0.05-0.07-0.03-0.05-0.01-0.04-0.07
Surprise------------
Timing--------Pre-marketAfter-hours--

Key Statistics & Ratios

Market Cap145.01M
Enterprise Value134.16M
Trailing P/E0.00
Forward P/E0.00
Price / Sales17.35
Price / Book10.20
EPS-0.09
Book Value0.17
Revenue (TTM)8.36M
Gross Profit (TTM)8.36M
EBITDA-8.47M
Profit Margin-99.50%
Operating Margin-100.83%
Return on Equity-66.39%
Return on Assets-27.75%
Shares Outstanding92.96M
Shares Float61.44M
Beta1.06
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%